US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Patent 7959925 was granted and assigned to Providence Health System on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+366 characters)
Article
Patent abstract
Compositions including a trimeric OX-40 fusion protein are disclosed. Also disclosed are methods for enhancing the immune response of a mammal to an antigen by engaging the OX-40 receptor on the surface of T-cells involving administering to the mammal a composition comprising a trimeric OX-40 fusion protein and a pharmaceutically acceptable carrier.
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07959925 Trimeric OX40-immunoglobulin fusion protein and methods of use US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Infobox
Patent Number
0795992500
Patent Number
795992500
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079599250
Date of Patent
June 14, 2011
0Patent Application Number
126186780
Date Filed
November 13, 2009
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079599250
Date of Patent
June 14, 2011
0Patent Application Number
126186780
Date Filed
November 13, 2009
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07959925
Date of patent
June 14, 2011
Patent application number
12618678
Date Filed
November 13, 2009
Patent primary examiner
Find more entities like US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
